AMG 073

DRUG6 trials

Sponsors

Amgen

Conditions

End Stage Renal DiseaseHyperparathyroidismParathyroid NeoplasmsRenal OsteodystrophySecondary Hyperparathyroidism

Phase 2

Treatment for Patients With Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)

CompletedNCT00110929

AmgenEnd Stage Renal Disease

Start: 2002-11-30Target: 850Updated: 2010-04-23

12-month Study of AMG 073 in Renal Osteodystrophy

CompletedNCT00527085

AmgenRenal Osteodystrophy

Start: 2001-10-31End: 2003-08-31Target: 45Updated: 2013-05-08

Phase 3

A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients

CompletedNCT00037635

AmgenEnd Stage Renal Disease, Secondary Hyperparathyroidism

Start: 2001-12-31End: 2003-03-31Target: 400Updated: 2013-05-08

A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis

CompletedNCT00042653

AmgenEnd Stage Renal Disease, Secondary Hyperparathyroidism

Start: 2002-05-31End: 2003-07-31Target: 380Updated: 2013-05-08

Safety and Efficacy Study of AMG 073 in Hemodialysis Subjects

CompletedNCT00527267

AmgenHyperparathyroidism

Start: 2002-02-28End: 2003-04-30Target: 320Updated: 2009-01-26

Phase 4

A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer

CompletedNCT00037518

AmgenHyperparathyroidism, Parathyroid Neoplasms

Start: 2001-04-30Target: 46Updated: 2013-05-08